Clinical trials
Phase 2 Prediabetic State trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Withdrawn | 4 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Washington University School of Medicine | 2 |
| Brigham and Women's Hospital | 1 |
| Diana Jalal | 1 |
| Florida State University | 1 |
| Gary L. Pierce | 1 |
| Indiana University | 1 |
| Mayo Clinic | 1 |
| National University of Natural Medicine | 1 |
| NewChapter, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prediabetic State | 20 |
| Diabetes Mellitus | 6 |
| Diabetes Mellitus, Type 2 | 6 |
| Obesity | 6 |
| Glucose Intolerance | 4 |
| Insulin Resistance | 3 |
| Atherosclerosis | 2 |
| Cardiovascular Diseases | 2 |
| Inflammation | 2 |
| Non-alcoholic Fatty Liver Disease | 2 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.